Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis
- 28 February 2008
- journal article
- clinical trial
- Published by Springer Nature in Clinical Rheumatology
- Vol. 27 (6) , 795-797
Abstract
The aim of this study was to investigate the effect of anti-tumor necrosis factor alpha (anti-TNF) treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis (RA). Nineteen women with RA starting anti-TNF treatment were included in the study. Disease activity, body composition, lumbar spine bone mineral density (BMD) and serum adiponectin concentrations were measured at baseline and after 1 year of follow-up. No important changes on body composition and lumbar spine BMD were observed, while the serum levels of adiponectin levels increased after 1 year of anti-TNF treatment (p = 0.02). Anti-TNF treatment in women with RA does not have any significant effect on body composition; however, it is associated with increase in adiponectin levels which may ameliorate the systemic inflammatory response state associated with RA.Keywords
This publication has 21 references indexed in Scilit:
- Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritisModern Rheumatology, 2007
- Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral boneCytokine, 2007
- TNF-α Alters Visfatin and Adiponectin Levels in Human FatHormone and Metabolic Research, 2007
- Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Blood Leptin and Adiponectin as Possible Mediators of the Relation Between Fat Mass and BMD in Perimenopausal WomenJournal of Bone and Mineral Research, 2004
- Natural vs Vaccine-Acquired Immunity to Cytomegalovirus—ReplyJAMA, 2003
- Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinaseNature Medicine, 2002
- Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.Journal of Clinical Investigation, 1994